EPISODE · Feb 23, 2025 · 11 MIN

Exenatide in Parkinson’s disease phase 3 trial

from Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology · host Amer Ghavanini

Exenatide once a week versus placebo as a potential diseasemodifying treatment for people with Parkinson’s disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial #Neurology #Parkinson

Episode metadata supplied by the publisher feed · Published Feb 23, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Exenatide in Parkinson’s disease phase 3 trial

0:00 11:10

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology?

This episode is 11 minutes long.

When was this Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology episode published?

This episode was published on February 23, 2025.

Can I download this Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!